Information Journal Paper
APA:
Copy. (2019). Innovative Curative Treatment of Beta Thalassemia: Cost-Efficacy Analysis of Gene Therapy Versus Allogenic Hematopoietic Stem-Cell Transplantation. HUMAN GENE THERAPY, 30(6), 753-761. SID. https://sid.ir/paper/779264/en
Vancouver:
Copy. Innovative Curative Treatment of Beta Thalassemia: Cost-Efficacy Analysis of Gene Therapy Versus Allogenic Hematopoietic Stem-Cell Transplantation. HUMAN GENE THERAPY[Internet]. 2019;30(6):753-761. Available from: https://sid.ir/paper/779264/en
IEEE:
Copy, “Innovative Curative Treatment of Beta Thalassemia: Cost-Efficacy Analysis of Gene Therapy Versus Allogenic Hematopoietic Stem-Cell Transplantation,” HUMAN GENE THERAPY, vol. 30, no. 6, pp. 753–761, 2019, [Online]. Available: https://sid.ir/paper/779264/en